TrialMedical oncology (Northwood, London, England)2015

Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial.

Sebastian Ochenduszko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.